Marshall Edwards, an oncology company focused on the clinical development of therapeutics targeting cancer metabolism, has elected William D. Rueckert to its board of directors.
Rueckert's experience covers industries including healthcare, financial services and natural resources. He is the managing member of Oyster Management, an investment fund specializing in community banks. From 1991 to 2006 he was president and director of Rosow & Company. Rueckert previously served as a director of Marshall Edwards from March 2007 until March 2009 and soon after was appointed as a director of Novogen. He is also a member of the board of directors of Chelsea Therapeutics International.